Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
[ad_1]
Flakes, on June 12, 2023, Hillerod, Denmark Nordisk A / S moves along a conveyor in production facilities.
Bloomberg | Bloomberg | Getty pictures
Denmark is expected to grow economic growths of economists that are expected to weaken this year in pharmaceutical exports – but according to the International Monetary Fund, there will be many factors contributing US tariffs in the Pharra industry.
The BVF said on Tuesday Last sheet about Nordic country In 2024, 3.7% increased by 3.7% to the Denmark, and in 2026, it will take place in the expected vulnerabilities due to the average and 1.8% this year, including the presence of pharmaceutical goods.
The Foundation noted that the Danish drug products nor the borders of Denmark will potentially be potentially protected in the US pharmacy imports.
Denmark drills are increasingly relying on a “merchant and processing” system that belongs to the intellectual property within the majority of drugs, Produces products producing products producing products with drug companies and provide products.
“The United States is the main trading partner;, however, US tariffs will be limited to direct impact on US tariffs, but increased trade and trade policy said.
In 2026, the average term growth of the Foundation, the average term growth of the “reflection of an adult pharmaceutical sector and less operating elderly population” said “the medium-term growth was projected.
Last autumn, IMF economists noted that the growth of Denmark was managed by “exceptional art” in its Pharma industry The rest of the economy remained “relatively inferred.”
The Fund was Denmark pharmaceutical giant Novo NordiskDiabetes and Weight loss medications, Wegovy and Ozempic’s growth driver, in the early 1990s reporting the sale of the company from 8.3% to 8.3% to 8.3%
Destroyed danger by Trump
A larger title for a larger European drug industry is the threat of US President Donald Trump’s tariffs on drug imports.
The pharmacy was released in April in April, but was released in the president’s global industry, but so far demanded that the drugs exported separately and landing in the US drug prices.
Pointing to the issue, Trump has signed an executive order to reduce drug prices to adapt the prices paid abroad on Monday, Monday.
The president did not refer to specific nations, but other developed countries pointed out that there are some additional assistance, there are some additional countries and are good. “
“Basically, it is equal to what we do,” Trump said during the press on Monday. “We will pay the lowest price in the world. Who will receive the lowest price, we will receive, the price we will get.”
White House officials did not disclose which drugs will be applied, but it will affect the trading market and Medicare and Medicaid.
In 2022, all drug prices for all drugs (brands and generations) were three times higher than the price of 33 OECD comparison countries, According to the US Department of Health and Human Services in 2024.
US President Donald Trump Gestures, Washington, DC, May 12, 12 May 2025 signed an order on a prescription medication during the Washington, the United States Roosevelt room in the Roosevelt room. Reuters / Nathan Howard
Nathan Howard | Reuters
Tariffs in Pharmaceutical Imports It is described as “Damocles Sword” hanging in the Pharma industryWith CEOs, a proposal to avoid collection warned the United States to be a shot of large continental players.
Federation of Pharmaceutical Industry and Circles (EFPIA), including EFPIA (EFPIA) – Novo Nordisk, including Bayer, Astrazeneca, GSK, Roche and Sanofi – European Commission President Ursula Von Der Leyen “Fast and radical policy in April will be reduced to the United States after the rapid, radical policy change”
He said that the interrogation of members was at risk as a result of capital expenditures and research and development investments worth about 100 billion euros ($ 112 billion).
“Now, each US investor’s metric leads Europe for capital, intellectual property and innovation approval. EFPIA said.
– CNBC’s Annika Kim Constantino and Karen Gilchrist gave notice to this story
[ad_2]
Source link